|
⚲
|
| Valence Advantage Life Sciences Fund II LP | |
|---|---|
| Firm |
Valence Life Sciences LLC
✚
|
| Fund # | 805-3436476673 |
| CIK # | |
| Sale | |
| Fund | Venture Capital Fund |
| Phone | |
| Address | |
| Source | [EDGAR] [IAPD] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2026 |
|---|---|
| Valence Life Sciences GP II LLC | |
| A Leheny | |
| Scott Morenstein | |
| Eric Roberts | |
| Jay Cecil |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Gruenstein Investments LLC
✚
|
0.1 | |
|
GST Management LLC
✚
|
0.1 | |
|
J Mandwelle Capital Strategies LLC
✚
|
0.1 | |
|
Richmond Quantitative Advisors LLC
✚
|
0.1 | |
|
CWM Partners LLC
✚
|
0.1 | |
|
Munakata Associates LLC
✚
|
0.1 | |
|
Swiss Finance Management International Sa
✚
|
0.1 | |
|
Argus Equity Partners LLC
✚
|
0.1 | |
|
John T McCarthy LLC
✚
|
0.1 | |
|
Amplify Endowment Management LLC
✚
|
0.1 |